Sarah Pringle
The Florida provider of at-risk primary care for seniors has grown from one to 35 clinics in three years.
PPD's value has grown more than 288 percent since H&F and Carlyle backed the company in December 2011, with its IPO assigning it an initial enterprise value of ~$14bn.
Pharmaceutical Product Development goes public eight years after H&F and Carlyle completed its buyout.
Current healthcare efforts are being led by members that include Greg Brenneman, Richard Zannino, Kevin O’Brien and Shane McHugh.
The Chicago buyout firm took the healthcare IT security company private in a $544m transaction in 2019.
Industry veteran John Damgaard said the partnership will seek an initial platform in HCIT generating anywhere from $15mn to $65mn in revenue.
The New York firm, formed by former Apax exec Buddy Gumina, eyes additional opportunities for investment in over-the-counter branded products.
J.P. Morgan Asset Management joined Riata as an investor a year ago to supporting AEG's aggressive M&A playbook.
The Edgemont Partners-run auction for the family-run company kicked off in late 2019.
The medical imaging software company's revenue has grown at 20-to-25 percent YOY since Canadian investor Novacap's 2016 investment, an exec at the firm said.